Jump to content

Sodium Bicarbonate: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
home-claude punt-list stub-split, Top 300 #227
 
home-claude house-rule fix (terminology / spelling)
 
Line 18: Line 18:
| pregnancy        = Routine antacid and acidosis correction acceptable
| pregnancy        = Routine antacid and acidosis correction acceptable
| legal            = [[USLegal:Prescription only|Rx-only]] for IV formulations; OTC for oral
| legal            = [[USLegal:Prescription only|Rx-only]] for IV formulations; OTC for oral
| mechanism        = <vote slug="nahco3-mech-claim">Sodium bicarbonate raises serum pH directly via the carbonic acid / bicarbonate buffer system; in TCA overdose its benefit is partly pH-driven (reducing free drug) and partly sodium-driven (overcoming TCA sodium-channel blockade), which is why hypertonic 8.4% is preferred over isotonic.</vote> Bicarbonate is not benign: high-volume use produces hypernatremia, metabolic alkalosis, hypokalemia, and (in arrest) paradoxical intracellular acidosis<ref name="nahco3-label" />.
| mechanism        = <vote slug="nahco3-mech-claim">Sodium bicarbonate raises serum pH directly via the carbonic acid / bicarbonate buffer system; in TCA overdose its benefit is partly pH-driven (reducing the free unbound fraction) and partly sodium-driven (overcoming TCA sodium-channel blockade), which is why hypertonic 8.4% is preferred over isotonic.</vote> Bicarbonate is not benign: high-volume use produces hypernatremia, metabolic alkalosis, hypokalemia, and (in arrest) paradoxical intracellular acidosis<ref name="nahco3-label" />.
}}
}}


== References ==
== References ==
<references />
<references />

Latest revision as of 04:44, 23 May 2026

Sodium bicarbonate is a systemic alkalinizing agent and antacid, used intravenously in severe metabolic acidosis, hyperkalemia with cardiotoxicity, tricyclic-antidepressant overdose with QRS widening, and (historically) cardiac arrest; orally as an antacid and urinary alkalinizer; and as the carrier base for many effervescent formulations[1]. Routine bicarbonate administration in cardiac arrest was removed from ACLS algorithms because it did not improve survival and worsened intracellular acidosis; the remaining strong indications are narrow and physiology-driven.

Sodium bicarbonate
Neut, many generic; OTC oral: Alka-Seltzer (with aspirin/citric acid), baking soda

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Common uses
Severe metabolic acidosis0, Hyperkalemia with ECG changes0, Tricyclic-antidepressant overdose with QRS widening0, Urinary alkalinization (salicylate or methotrexate toxicity, uric-acid stones)0, Symptomatic antacid (oral)0
Pharmacy
Starting dose
IV: 1 mEq/kg bolus in arrest indication, then titrated to ABG and clinical status; PO: 325-2000 mg up to QID as antacid
Preparations
4.2%, 7.5%, 8.4% IV (1 mEq/mL at 8.4%); 325, 650 mg oral tablets; bulk powder
US FDA Max
No fixed maximum; titrated to pH and bicarbonate level; chronic high oral doses cause metabolic alkalosis and volume overload
Pharmacology
Routes
IV, oral
Onset
Immediate (IV); within minutes (oral antacid)
Duration
IV: hours, dependent on ongoing acid load; oral antacid: ~30 minutes
Half-life
Not applicable (electrolyte and buffer)
Bioavailability
100% (IV); rapidly neutralized by gastric acid (oral)
Pregnancy
Routine antacid and acidosis correction acceptable
Legal status
Rx-only for IV formulations; OTC for oral
Purported mechanism
Sodium bicarbonate raises serum pH directly via the carbonic acid / bicarbonate buffer system; in TCA overdose its benefit is partly pH-driven (reducing the free unbound fraction) and partly sodium-driven (overcoming TCA sodium-channel blockade), which is why hypertonic 8.4% is preferred over isotonic.0 Bicarbonate is not benign: high-volume use produces hypernatremia, metabolic alkalosis, hypokalemia, and (in arrest) paradoxical intracellular acidosis[1].

References

  1. 1.0 1.1 FDA Prescribing Information, Sodium Bicarbonate Injection, Hospira, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018802s022lbl.pdf